CareTrust's $733 million stock deal comes with a wait for the cash

CareTrust has completed a stock offering worth $733.1 million at the public sale price. It has yet to receive the cash from that sale. Banks borrowed and sold existing shares, with CareTrust expecting to issue new shares and collect the money later.

The arrangement gives the healthcare-property investor flexibility as it buys care homes. It also creates a timing question for shareholders: when will the new capital start earning returns, and when will the extra shares begin sharing in those returns?

The sale is done. Settlement comes later.

The November 13 closing covered 19.55 million shares, including an additional 2.55 million after the underwriters exercised their option in full. The public offering price was $37.50 a share.

After the underwriting discount, the initial price CareTrust would receive is $36 a share. Full settlement at that starting price would produce $703.8 million before other expenses. The final amount changes with interest-rate and dividend adjustments specified in the agreements.

CareTrust expects to settle by delivering new shares for cash, on dates it chooses no later than November 12, 2027. It can instead use cash or net-share settlement, subject to the agreements' conditions, which would change the proceeds.

How much larger could the share count become?

Research by Ticker Byline shows that the 19.55 million shares represent about 7.6% of the shares outstanding on November 10. Full delivery would lift that count from 257.7 million to 277.2 million, before any other share changes.

That is the potential increase in shares, rather than a forecast of the effect on earnings per share. The other side of the transaction is the income CareTrust can earn from investing the proceeds. Delaying settlement helps it match the capital raised to the timing of purchases.

A growing care-home portfolio needs funding

The company reported about $2.9 billion invested in 2026 through its November 5 update. Its remaining investment pipeline was $1.2 billion.

One large commitment is a 45-home U.K. transaction with LNT Care Developments. CareTrust acquired the first 23 homes on October 1 for £552 million. The other 22 homes, priced at £528 million, are expected to close in stages through 2027.

It is also using debt. In October, CareTrust added a $700 million term loan and expanded its revolving credit line to $2 billion. It reported $425 million drawn on that line and about $100 million of cash in its November 5 update. Those balances predate the new stock offering.

Growth has to reach each share

Third-quarter normalized funds from operations rose 20% to 54 cents a share. This adjusted property-industry earnings measure adds back real-estate depreciation and makes further adjustments for selected gains, costs and other items. Reported net income attributable to CareTrust was $83.7 million, or 35 cents a share, with per-share earnings unchanged from a year earlier.

CareTrust's November 5 annual forecast put normalized funds from operations at $2.08 to $2.09 a share. It assumed no debt or equity issues beyond those already made and no investments beyond those made or announced at that point. It is an earlier forecast, rather than a fresh estimate incorporating every possible settlement and purchase under the new deal.

The next useful milestones are settlement of the forwards, investment of the money and the income those investments add per share. The CareTrust company profile tracks those steps and the completed portion of the U.K. acquisition.